Characterization of human iPSC-derived astrocytes with potential for disease modeling and drug discovery
Open Access
- 13 July 2020
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 731, 135028
- https://doi.org/10.1016/j.neulet.2020.135028
Abstract
No abstract availableFunding Information
- ALS Canada/Brain Canada Hudson Translational Team
- Canadian Institutes for Health Research and Fonds de la recherche en Sante-Quebec
This publication has 52 references indexed in Scilit:
- Astrocyte pathology and the absence of non-cell autonomy in an induced pluripotent stem cell model of TDP-43 proteinopathyProceedings of the National Academy of Sciences of the United States of America, 2013
- Genomic Analysis of Reactive AstrogliosisJournal of Neuroscience, 2012
- Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanismsCell Death & Differentiation, 2011
- Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosisProceedings of the National Academy of Sciences of the United States of America, 2011
- Astrocytes from familial and sporadic ALS patients are toxic to motor neuronsNature Biotechnology, 2011
- Uniquely Hominid Features of Adult Human AstrocytesJournal of Neuroscience, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALSJournal of Neuroscience, 2007
- Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemiaHistopathology, 2007
- Production of monocyte chemoattractant protein‐1 in amyotrophic lateral sclerosisMuscle & Nerve, 2005